研究者業績
基本情報
- 所属
- 藤田医科大学 研究推進本部 感染症研究センター ウイルス感染動態研究部門 准教授
- 学位
- 博士(歯学)(大阪大学)
- 連絡先
- tomohiko.sadaoka
fujita-hu.ac.jp - J-GLOBAL ID
- 200901074193593340
- researchmap会員ID
- 5000025000
研究分野
1学歴
1-
- 2006年3月
論文
30-
Journal of medical virology 97(12) e70750 2025年12月Varicella-zoster virus (VZV) causes varicella in children, establishes lifelong latency and reactivates to cause herpes zoster later in life. Implementation of routine varicella vaccination in Japan since 2014 has reduced varicella cases, however, breakthrough varicella still occurs. This study aimed to clarify the current distribution of VZV clade among pediatric varicella patients and adults with VZV-associated central nervous system (CNS) infections in Japan. Skin swabs were collected from varicella patients (< 15 years) in Aichi Prefecture (September 2015-August 2017). Cerebrospinal fluid (CSF) samples were obtained from adult patients (> 15 years) with VZV-associated CNS infections (November 2014-June 2023). VZV DNA was detected by PCR, and its clade was determined by sequencing open reading frame (ORF) 22 and ORF37 regions. Wild-type and Oka vaccine strains were distinguished by loop-mediated isothermal amplification (LAMP) method. Of 124 pediatric swab samples and 62 adult CSF samples 94.4% belonged to clade 2 and 4.8% clade 1. No clade 1 samples were detected in CSF samples. No vaccine strain was detected. Clinical characteristics did not differ significantly among clades. Clade 2 VZV predominates in both pediatric varicella and adult VZV-related CNS infections in Japan with sporadic clade 1 varicella cases.
-
Nature cell biology 25(3) 508-508 2023年2月21日
-
Nature cell biology 24(11) 1595-1605 2022年10月17日 査読有りSalivary glands act as virus reservoirs in various infectious diseases and have been reported to be targeted by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the mechanisms underlying infection and replication in salivary glands are still enigmatic due to the lack of proper in vitro models. Here, we show that human induced salivary glands (hiSGs) generated from human induced pluripotent stem cells can be infected with SARS-CoV-2. The hiSGs exhibit properties similar to those of embryonic salivary glands and are a valuable tool for the functional analysis of genes during development. Orthotopically transplanted hiSGs can be engrafted at a recipient site in mice and show a mature phenotype. In addition, we confirm SARS-CoV-2 infection and replication in hiSGs. SARS-CoV-2 derived from saliva in asymptomatic individuals may participate in the spread of the virus. hiSGs may be a promising model for investigating the role of salivary glands as a virus reservoir.
-
Viruses 13(11) 2289-2289 2021年11月16日 査読有り最終著者責任著者Primary varicella-zoster virus (VZV) infection leads to varicella and the establishment of lifelong latency in sensory ganglion neurons. Reactivation of latent VZV causes herpes zoster, which is frequently associated with chronic pain. Latent viral gene expression is restricted to the VZV latency-associated transcript (VLT) and VLT-ORF63 (VLT63) fusion transcripts. Since VLT and VLT63 encode proteins that are expressed during lytic infection, we investigated whether pVLT and pVLT-ORF63 are essential for VZV replication by performing VZV genome mutagenesis using CRISPR/Cas9 and BAC technologies. We first established that CRISPR/Cas9 can efficiently mutate VZV genomes in lytically VZV-infected cells through targeting non-essential genes ORF8 and ORF11 and subsequently show recovery of viable mutant viruses. By contrast, the VLT region was markedly resistant to CRISPR/Cas9 editing. Whereas most mutants expressed wild-type or N-terminally altered versions of pVLT and pVLT-ORF63, only a minority of the resulting mutant viruses lacked pVLT and pVLT-ORF63 coding potential. Growth curve analysis showed that pVLT/pVLT-ORF63 negative viruses were viable, but impaired in growth in epithelial cells. We confirmed this phenotype independently using BAC-derived pVLT/pVLT-ORF63 negative and repaired viruses. Collectively, these data demonstrate that pVLT and/or pVLT-ORF63 are dispensable for lytic VZV replication but promote efficient VZV infection in epithelial cells.
-
Journal of Virology 95(22) 2021年10月27日 査読有り
-
Nature Communications 11(1) 2020年12月10日 査読有り最終著者責任著者
-
Journal of Virology 94(11) 2020年5月18日 査読有り
-
Nat Commun. 10(1) 754-754 2019年12月 査読有り
-
Nature Communications 9(1) 1167-1167 2018年12月 査読有り筆頭著者Varicella-zoster virus (VZV), an alphaherpesvirus, establishes lifelong latent infection in the neurons of >90% humans worldwide, reactivating in one-third to cause shingles, debilitating pain and stroke. How VZV maintains latency remains unclear. Here, using ultra-deep virus-enriched RNA sequencing of latently infected human trigeminal ganglia (TG), we demonstrate the consistent expression of a spliced VZV mRNA, antisense to VZV open reading frame 61 (ORF61). The spliced VZV latency-associated transcript (VLT) is expressed in human TG neurons and encodes a protein with late kinetics in productively infected cells in vitro and in shingles skin lesions. Whereas multiple alternatively spliced VLT isoforms (VLTly) are expressed during lytic infection, a single unique VLT isoform, which specifically suppresses ORF61 gene expression in co-transfected cells, predominates in latently VZV-infected human TG. The discovery of VLT links VZV with the other better characterized human and animal neurotropic alphaherpesviruses and provides insights into VZV latency.
-
Viruses 10(7) 2018年6月28日Primary varicella-zoster virus (VZV) infection causes varicella (chickenpox) and the establishment of a lifelong latent infection in ganglionic neurons. VZV reactivates in about one-third of infected individuals to cause herpes zoster, often accompanied by neurological complications. The restricted host range of VZV and, until recently, a lack of suitable in vitro models have seriously hampered molecular studies of VZV latency. Nevertheless, recent technological advances facilitated a series of exciting studies that resulted in the discovery of a VZV latency-associated transcript (VLT) and provide novel insights into our understanding of VZV latency and factors that may initiate reactivation. Deducing the function(s) of VLT and the molecular mechanisms involved should now be considered a priority to improve our understanding of factors that govern VZV latency and reactivation. In this review, we summarize the implications of recent discoveries in the VZV latency field from both a virus and host perspective and provide a roadmap for future studies.
-
Advances in Experimental Medicine and Biology 1045 123-142 2018年 招待有り筆頭著者責任著者
-
Journal of Virology 92(1) 2018年 査読有り筆頭著者
-
Journal of Virology 91(17) 2017年9月1日 査読有り筆頭著者
-
Proceedings of the National Academy of Sciences of the United States of America 113(17) E2403-E2412 2016年4月26日 査読有り筆頭著者
-
Journal of Clinical Immunology 35(2) 112-118 2015年2月 査読有り
-
Journal of Virology 88(1) 188-201 2014年1月1日 査読有り筆頭著者
-
Journal of Virology 84(7) 3488-3502 2010年4月1日 査読有り筆頭著者
-
Current topics in microbiology and immunology 342 147-54 2010年Glycoprotein M (gM) is conserved among herpesviruses. Important features are its 6-8 transmembrane domains without a large extracellular domain, localization to the virion envelope, complex formation with another envelope glycoprotein, glycoprotein N (gN), and role in virion assembly and egress. In varicella-zoster virus (VZV), the gM homolog is encoded by ORF50. VZV gM is predicted to be an eight-transmembrane envelope glycoprotein with a complex N-linked oligosaccharide. It mainly localizes to the trans-Golgi network, where final virion envelopment occurs. Studies in which VZV gM or its partner gN were disrupted suggest that the gM/gN complex plays an important role in cell-to-cell spread. Here, we summarize the biological features of VZV gM, including our recent findings on its characterization and function.
-
Virology 377(2) 289-295 2008年8月 査読有り
-
Journal of Virology 82(2) 795-804 2008年1月15日 査読有り筆頭著者
-
Journal of Virology 81(22) 12654-12665 2007年11月15日 査読有り筆頭著者
-
Journal of General Virology 87(3) 501-508 2006年3月1日 査読有り筆頭著者
-
Journal of General Virology 87(2) 277-285 2006年2月1日 査読有り
-
Journal of Virology 78(15) 7969-7983 2004年8月1日 査読有り
-
Journal of Virology 78(9) 4609-4616 2004年5月1日 査読有り<title>ABSTRACT</title> The human herpesvirus 6 (HHV-6) glycoprotein H (gH)-glycoprotein L (gL) complex associates with glycoprotein Q (gQ) (Y. Mori, P. Akkapaiboon, X. Yang, and K. Yamanishi, J. Virol. 77:2452-2458, 2003), and the gH-gL-gQ complex interacts with human CD46 (Y. Mori, X. Yang, P. Akkapaiboon, T. Okuno, and K. Yamanishi, J. Virol. 77:4992-4999, 2003). Here, we show that the HHV-6 U47 gene, which is a positional homolog of the human cytomegalovirus glycoprotein O (gO) gene, encodes a third component of the HHV-6 gH-gL-containing envelope complex. A monoclonal antibody (MAb) against the amino terminus of HHV-6 gO reacted in immunoblots with protein species migrating at 120 to 130 kDa and 74 to 80 kDa in lysates of HHV-6-infected cells and with a 74- to 80-kDa protein species in purified virions. The 80-kDa form of gO was coimmunoprecipitated with an anti-gH MAb, but an anti-gQ MAb, which coimmunoprecipitated gH, did not coprecipitate gO. Furthermore, the gH-gL-gO complex did not bind to human CD46, indicating that the complex was not a ligand for CD46. These findings suggested that the viral envelope contains at least two kinds of tripartite complexes, gH-gL-gQ and gH-gL-gO, and that the gH-gL-gO complex may play a role different from that of gH-gL-gQ during viral infection. This is the first report of two kinds of gH-gL complexes on the viral envelope in a member of the herpesvirus family.
MISC
4-
ウイルス 60(2) 221-236 2010年ヒトヘルペスウイルス6(human herpesvirus 6 : HHV-6)は,小児期のポピュラーな疾患のひとつである突発性発疹の原因ウイルスであり,90%以上の成人の体内に潜伏感染している.近年は,移植後患者におけるHHV-6再活性化による脳炎が問題となっている.また,HHV-6と薬剤過敏症症候群との関連性も示唆されている.<BR> ヒトヘルペスウイルス7(human herpesvirus 7 : HHV-7)は,健康成人の末梢血単核球から分離されたウイルスであり,HHV-6感染後の突発性発疹を引き起こすことが知られている.両者は,βヘルペスウイルス亜科に属する近縁なウイルスであり,主にT細胞において感染増殖し,子孫ウイルスを形成する.
書籍等出版物
1講演・口頭発表等
35-
49th Annual International Herpesvirus Workshop 2025年7月26日
-
45th Annual International Herpesvirus Workshop 2021年8月6日 招待有り
-
1st International Varicella-Zoster Symposium 2021年7月2日 招待有り
共同研究・競争的資金等の研究課題
7-
日本学術振興会 科学研究費助成事業 2021年4月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(B) 2021年4月 - 2025年3月
-
学術研究助成基金助成金/基盤研究(C) 2017年4月 - 2020年3月
-
科学研究費補助金/新学術領域研究 2017年4月 - 2019年3月
-
日本学術振興会 科学研究費補助金/基盤研究(C) 2012年4月 - 2015年3月